Integrated Peptide Products and Services Accelerate Targeted Therapy Research
New York, USA – February 8, 2022 – A groundbreaking discovery about peptide inhibitors was recently published in the journal Drugs in R&D, describing the development and validation of a 13-amino acid peptide inhibitor of the problem-causing coronavirus 2 (SARS-CoV-2). This finding in combination with numerous peptide research reveals the broad prospect of peptide application in targeted therapy.
BOC Sciences, the pioneering biochemical supplier, has been dedicated to developing a series of research-use or industrial products for years. Its sub-brand AAPEP is recognized as a professional in the provision of peptides, amino acids, and resins. Meanwhile, AAPEP also demonstrates convincing strength in serving laboratories with tailored peptide-associated techniques.
Based on the thorough insight into the effectiveness of peptides for the treatment of cancers, diabetes, and HIV, BOC Sciences devotes tremendous energies to peptide exploration, aiming at developing abundant materials for drug studies or manufacturing. Its dominating products involve functional peptides, peptide APIs, peptide inhibitors, cosmetic peptides, and peptide synthesis reagents.
Peptides must be built from an exact sequence of amino acids, indicating that the ability to remove any excess amino acids which are not part of the sequence before adding another is a crucial step in the manufacturing process. With regard to this procedure, BOC Sciences employs the advanced solid phase method that firstly couples amino acids to insoluble solid supports and then washes away the redundant ones from the support-bound growing peptides. Owing to the advantage of solid phase method that it can be easily automated, BOC Sciences enables rapid peptide synthesis and bulk production, competent to cope with intensive demands.
Experts of BOC Sciences also rack their brains to address the challenge of improving peptide stability, the vital factor affecting peptide drug discovery. They find that the introduction of unnatural amino acids into peptides can achieve ideal consistency in drug properties, and sometimes even boost their activity. Therefore, BOC Sciences utilizes asymmetric synthesis of amino acids through not only the usual methods but also the rare ones that introduce aryl groups on the a-carbon of amino acids to prepare valuable a-aryl quaternary amino acids. Currently, the amino acids available at BOC Sciences have top-level purity of 95% to 99%, strong evidence of BOC Sciences’ reliability as a leading biochemical manufacturer.
The amino acid and peptide products at BOC Sciences are sought after by a large number of customers for the superb quality and flexibility in scales. “We are committed to acting as a facilitator in drug discovery who will provide trustworthy supportive products and services,” the chief executive announced.
About
BOC Sciences is a reputable biochemical producer based in the United States. Working with versatile experts, BOC Sciences has cultivated many popular peptide products applied in pharmaceutical research and production. Besides, it also endeavors to offer thoughtful services that can meet diverse needs.
Media Contact
Company Name: BOC Sciences
Contact Person: Alex Brown
Email: Send Email
Phone: 1-631-485-4226
Country: United States
Website: https://aapep.bocsci.com
